Business Description
Etropal AD
ISIN : BG1100001038
Total Employee Number:
102Description
Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.71 | |||||
Debt-to-EBITDA | 4.44 | |||||
Interest Coverage | 3.06 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.98 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 44.2 | |||||
3-Year EBITDA Growth Rate | 54.4 | |||||
3-Year FCF Growth Rate | 56.6 | |||||
3-Year Book Growth Rate | 1.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 99.96 | |||||
3-1 Month Momentum % | 9.57 | |||||
6-1 Month Momentum % | 9.57 | |||||
12-1 Month Momentum % | -38.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.7 | |||||
Quick Ratio | 0.21 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 112.72 | |||||
Days Sales Outstanding | 23.21 | |||||
Days Payable | 77.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -3.67 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 29.53 | |||||
Operating Margin % | 4.28 | |||||
Net Margin % | 1.5 | |||||
EBITDA Margin % | 6.82 | |||||
FCF Margin % | -0.71 | |||||
OCF Margin % | -0.71 | |||||
ROE % | 3.56 | |||||
ROA % | 1.6 | |||||
ROIC % | 4.55 | |||||
3-Year ROIIC % | 4889.72 | |||||
ROC (Joel Greenblatt) % | 3.86 | |||||
ROCE % | 5.4 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 89.03 | |||||
PE Ratio without NRI | 40.59 | |||||
Price-to-Owner-Earnings | 28.64 | |||||
PS Ratio | 1.35 | |||||
PB Ratio | 3.14 | |||||
Price-to-Tangible-Book | 3.14 | |||||
EV-to-EBIT | 56.04 | |||||
EV-to-EBITDA | 19.59 | |||||
EV-to-Revenue | 1.34 | |||||
EV-to-FCF | -170.84 | |||||
Price-to-GF-Value | 0.32 | |||||
Price-to-Projected-FCF | 3.03 | |||||
Price-to-Median-PS-Value | 0.2 | |||||
Price-to-Graham-Number | 2.38 | |||||
Earnings Yield (Greenblatt) % | 1.79 | |||||
FCF Yield % | -0.53 | |||||
Forward Rate of Return (Yacktman) % | -4.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Etropal AD Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 10.229 | ||
| EPS (TTM) (€) | 0.031 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.79 | ||
| 3-Year Sortino Ratio | -0.82 | ||
| Volatility % | 52.33 | ||
| 14-Day RSI | 99.96 | ||
| 14-Day ATR (€) | 0.01896 | ||
| 20-Day SMA (€) | 2.568 | ||
| 12-1 Month Momentum % | -38.54 | ||
| 52-Week Range (€) | 2.1 - 4.5 | ||
| Shares Outstanding (Mil) | 5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Etropal AD Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Etropal AD Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Etropal AD Frequently Asked Questions
What is Etropal AD(XBUL:ETR)'s stock price today?
The current price of XBUL:ETR is €2.76. The 52 week high of XBUL:ETR is €4.50 and 52 week low is €2.10.
When is next earnings date of Etropal AD(XBUL:ETR)?
The next earnings date of Etropal AD(XBUL:ETR) is .
Does Etropal AD(XBUL:ETR) pay dividends? If so, how much?
Etropal AD(XBUL:ETR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Etropal AD
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers